Trademarkia Logo

Australia

AU$
Trademark Search
SITAGLIPTIN/METFORMIN XR MK

View On IPO.GOV.AU

SITAGLIPTIN/METFORMIN XR MK
Lapsed: Notice of intention to defend not filed

Last updated on 15 Apr 2025

Owner Info

MANKIND PHARMA LIMITED

208 Okhla Industrial Estate

Phase - III, New Delhi, 110020 INDIA

Serial Number

2464388 filed on 8 Jul 2024

Correspondent

Gadens Lawyers

GPO Box 48,

Melbourne, VIC, 3001 AUSTRALIA,

SITAGLIPTIN/METFORMIN XR MK

Classification Information

Class [005]
medicinal, pharmaceutical and veterinary preparations

Mark Details

Serial Number

2464388

Registered On

NA

Renewal On

NA

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
15th Apr 2025Intention to defend not received notice (opponent) sent
15th Apr 2025Intention to Defend Not Received Notice (Defendant) correspondence sent
15th Apr 2025IP Right Lapsed correspondence sent
15th Apr 2025Status change to Lapsed/Not Protected
4th Mar 2025Grounds and Particulars Filed Notice (Opponent) correspondence sent
4th Mar 2025Grounds and Particulars Filed Notice (domestic defendant) correspondence sent
28th Feb 2025Statement of Grounds and Particulars Received
7th Feb 2025Intention to Oppose Filed Notice (Opponent) correspondence sent
7th Feb 2025Intention to Oppose Filed Notice (Domestic Defendant) correspondence sent
5th Feb 2025Notice of Intention to Oppose Registration Received